Kumar, Princy N.

Factors associated with death in critically ill patients with coronavirus disease 2019 in the US

Gupta, S., Hayek, S. S., Wang, W., Chan, L., Mathews, K. S., Melamed, M. L., Brenner, S. K., Leonberg-Yoo, A., Schenck, E. J., Radbel, J., et al. (2020) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesSepsis Diagnosis and Treatment

Cited by 957

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Gupta, S., Wang, W., Hayek, S. S., Chan, L., Mathews, K. S., Melamed, M. L., Brenner, S. K., Leonberg-Yoo, A., Schenck, E. J., Radbel, J., et al. (2021) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 535

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

Kozal, M., Aberg, J., Pialoux, G., Cahn, P., Thompson, M., Molina, J.-M., Grinsztejn, B., Diaz, R., Castagna, A., Kumar, P., et al. (2020) · New England Journal of Medicine

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 181

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial

Sims, M. D., Khanna, S., Feuerstadt, P., Louie, T. J., Kelly, C. R., Huang, E. S., Hohmann, E. L., Wang, E. E. L., Oneto, C., Cohen, S. H., et al. (2023) · JAMA Network Open

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 83

Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS

Havlir, D. V., Dubé, M. P., McCutchan, J. A., Forthal, D. N., Kemper, C. A., Dunne, M. W., Parenti, D. M., Kumar, P. N., White, A. C., Witt, M. D., et al. (1998) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 72